Susquehanna International Group’s NRX Pharmaceuticals NRXP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 6958 |
|
|
2025
Q1 | – | Sell |
-82,152
| Closed | -$181K | – | 6883 |
|
|
2024
Q4 | $181K | Buy |
+82,152
| New | +$181K | ﹤0.01% | 5374 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 6238 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 6294 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 6262 |
|
|
2023
Q4 | – | Sell |
-1,410
| Closed | -$3.67K | – | 6416 |
|
|
2023
Q3 | $3.67K | Buy |
+1,410
| New | +$3.67K | ﹤0.01% | 5403 |
|
|
2023
Q2 | – | Sell |
-8,062
| Closed | -$53.1K | – | 6222 |
|
|
2023
Q1 | $53.1K | Buy |
8,062
+5,289
| +191% | +$34.9K | ﹤0.01% | 5430 |
|
|
2022
Q4 | $30.8K | Sell |
2,773
-1,536
| -36% | -$17K | ﹤0.01% | 5277 |
|
|
2022
Q3 | $32K | Sell |
4,309
-4,448
| -51% | -$33K | ﹤0.01% | 5613 |
|
|
2022
Q2 | $53K | Buy |
8,757
+5,696
| +186% | +$34.5K | ﹤0.01% | 5221 |
|
|
2022
Q1 | $75K | Sell |
3,061
-4,835
| -61% | -$118K | ﹤0.01% | 5216 |
|
|
2021
Q4 | $377K | Buy |
7,896
+2,363
| +43% | +$113K | ﹤0.01% | 4196 |
|
|
2021
Q3 | $513K | Buy |
+5,533
| New | +$513K | ﹤0.01% | 3674 |
|
|
2019
Q3 | – | Sell |
-1,147
| Closed | -$120K | – | 4835 |
|
|
2019
Q2 | $120K | Buy |
+1,147
| New | +$120K | ﹤0.01% | 4105 |
|